189 related articles for article (PubMed ID: 25628047)
1. Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience.
Hearne BJ; Teare MD; Butt M; Donaldson L
BMJ Open; 2015 Jan; 5(1):e005576. PubMed ID: 25628047
[TBL] [Abstract][Full Text] [Related]
2. The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.
Lambertini M; Pinto AC; Ameye L; Jongen L; Del Mastro L; Puglisi F; Poggio F; Bonotto M; Floris G; Van Asten K; Wildiers H; Neven P; de Azambuja E; Paesmans M; Azim HA
Br J Cancer; 2016 Dec; 115(12):1471-1478. PubMed ID: 27802449
[TBL] [Abstract][Full Text] [Related]
3. Correlation between Nottingham Prognostic Index and Adjuvant! Online prognostic tools in patients with early-stage breast cancer in Mid-Western Ireland.
Quintyne KI; Woulfe B; Coffey JC; Gupta RK
Clin Breast Cancer; 2013 Aug; 13(4):233-8. PubMed ID: 23829889
[TBL] [Abstract][Full Text] [Related]
4. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
6. The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-stage Breast Cancer Patients.
Rejali M; Tazhibi M; Mokarian F; Gharanjik N; Mokarian R
Int J Prev Med; 2015; 6():93. PubMed ID: 26605014
[TBL] [Abstract][Full Text] [Related]
7. Prognostic models for breast cancer: a systematic review.
Phung MT; Tin Tin S; Elwood JM
BMC Cancer; 2019 Mar; 19(1):230. PubMed ID: 30871490
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer.
Cotter MB; Dakin A; Maguire A; Walshe JM; Kennedy MJ; Dunne B; Riain CÓ; Quinn CM
Virchows Arch; 2017 Sep; 471(3):321-328. PubMed ID: 28707056
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.
Okugawa H; Yamamoto D; Uemura Y; Sakaida N; Yamada M; Tanaka K; Kamiyama Y
Surg Today; 2005; 35(11):907-11. PubMed ID: 16249842
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.
Engelhardt EG; van den Broek AJ; Linn SC; Wishart GC; Rutgers EJT; van de Velde AO; Smit VTHBM; Voogd AC; Siesling S; Brinkhuis M; Seynaeve C; Westenend PJ; Stiggelbout AM; Tollenaar RAEM; van Leeuwen FE; van 't Veer LJ; Ravdin PM; Pharaoh PDP; Schmidt MK
Eur J Cancer; 2017 Jun; 78():37-44. PubMed ID: 28412587
[TBL] [Abstract][Full Text] [Related]
11. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
[TBL] [Abstract][Full Text] [Related]
12. The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment.
Wen J; Ye F; Li S; Huang X; Yang L; Xiao X; Xie X
PLoS One; 2015; 10(11):e0143537. PubMed ID: 26600129
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution.
D'Eredita' G; Giardina C; Martellotta M; Natale T; Ferrarese F
Eur J Cancer; 2001 Mar; 37(5):591-6. PubMed ID: 11290434
[TBL] [Abstract][Full Text] [Related]
14. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK
Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180
[TBL] [Abstract][Full Text] [Related]
15. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.
Blamey RW; Ellis IO; Pinder SE; Lee AH; Macmillan RD; Morgan DA; Robertson JF; Mitchell MJ; Ball GR; Haybittle JL; Elston CW
Eur J Cancer; 2007 Jul; 43(10):1548-55. PubMed ID: 17321736
[TBL] [Abstract][Full Text] [Related]
16. Prognostic models in male breast cancer.
van der Pol CC; Lacle MM; Witkamp AJ; Kornegoor R; Miao H; Bouchardy C; Borel Rinkes I; van der Wall E; Verkooijen HM; van Diest PJ
Breast Cancer Res Treat; 2016 Nov; 160(2):339-346. PubMed ID: 27671991
[TBL] [Abstract][Full Text] [Related]
17. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.
Schuil H; Derks M; Liefers GJ; Portielje J; van de Velde C; Syed B; Green A; Ellis I; Cheung KL; Bastiaannet E
J Geriatr Oncol; 2018 Nov; 9(6):635-641. PubMed ID: 29779800
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
[TBL] [Abstract][Full Text] [Related]
20. Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group.
Sundquist M; Thorstenson S; Brudin L; Nordenskjöld B
Breast Cancer Res Treat; 1999 Jan; 53(1):1-8. PubMed ID: 10206067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
